Offer - Urjas Oil for just ₹ 1
Mibe is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of High Cholesterol. Secondary and off-label uses of Mibe have also been mentioned below.
The optimal dosage of Mibe is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Mibe also has some side effects, the most common being Joint aches, Limb Pain, Respiratory tract infection. Besides the aforementioned side effects, there are other adverse effects of Mibe as well, which are listed below. Usually, these side effects of Mibe go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Mibe is Unknown for pregnant women and Moderate for women who are breastfeeding. In addition, Mibe's effects on the liver, heart and kidney are discussed below in the Mibe related warnings section.
Other contraindications of Mibe have been discussed in the sections ahead.
Drug interactions for Mibe have been reported in the medical literature. See below for a complete list.
You should also be aware that Mibe is safe while driving, and is addiction.
Mibe is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Mibe safe for pregnant women?
The effects of Mibe on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Mibe safe during breastfeeding?
Mibe can cause moderate side effects on breastfeeding women. If you feel its side effects, then stop taking this drug and consult your doctor. Take this medicine again only if your doctor advises to do so.
What is the effect of Mibe on the Kidneys?
Mibe may cause harmful effects on kidney. if you feel its having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Mibe on the Liver?
The liver can be affected by Mibe. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Mibe only after medical advice.
What is the effect of Mibe on the Heart?
Very few cases of side effects of Mibe on the heart have been reported.
Mibe should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Mibe unless your doctor advises you to do so -
Is this Mibe habit forming or addictive?
Mibe does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Mibe will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Mibe only as per medical advice.
Is it able to treat mental disorders?
No, Mibe cannot treat any kind of mental disorder.
Interaction between Food and Mibe
Mibe may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and Mibe
It is difficult to say anything about the effect of Mibe and alcohol. No research has been done on this yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zetia® (ezetimibe)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 641
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 545-546